Investor.synlogictx.com

Synlogic Initiates Phase 1 Study of SYNB8802 for the Treatment of

WEBThe Phase 1 clinical study has two parts: Part A is a multiple ascending dose study in healthy volunteers; Part B is a placebo controlled, cross-over design study in …

Actived: 6 days ago

URL: https://investor.synlogictx.com/news-releases/news-release-details/synlogic-initiates-phase-1-study-synb8802-treatment-enteric

Synlogic Provides Corporate Update and Outlook for 2024

WEBSynlogic Provides Corporate Update and Outlook for 2024. January 4, 2024. PDF Version. - Data review from pivotal Synpheny-3 study in PKU expected in H1 2024, with potential …

Category:  Health Go Health

Synlogic Presents Data on SYNB8802 for Enteric Hyperoxaluria at

WEBCAMBRIDGE, Mass., Sept. 10, 2021 /PRNewswire/ -- Synlogic, Inc. (Nasdaq: SYBX), a clinical stage company bringing the transformative potential of synthetic biology to …

Category:  Health Go Health

Synlogic Announces SYNB8802 Will Advance to Phase 1B Proof of …

WEBCAMBRIDGE, Mass., March 24, 2021 /PRNewswire/ -- Synlogic, Inc. (Nasdaq: SYBX), a clinical stage company bringing the transformative potential of synthetic biology to …

Category:  Health Go Health

A Synthetic Biotic, SYNB8802, Lowers Urinary Oxalate in

WEBFig. 2a. Oxalate and SYNB8802 transit through the stomach, small intestine, and colon are modeled according to a physiological function of chyme progression. b. SYNB8802 …

Category:  Health Go Health

Development of a Synthetic Biotic, SYNB8802, for the …

WEBSYNB8802 is a genetically engineered, non-colonizing strain of Escherichia coli Nissle 1917 (EcN). It was developed by engineering a pathway for oxalate degradation derived from …

Category:  Health Go Health

Safety and Tolerability of an Oxalate- Consuming Synthetic

WEBUnder normal conditions, dietary calcium forms a complex with oxalate in the gut lumen and renders it insoluble. Increased free fatty acids in the gut can lead to increased soluble …

Category:  Health Go Health

Synpheny-1: A Phase 2 Study of the Efficacy and Safety of

WEB3 (33) * SYNB1618: 1 discontinuation due to anxiety and GI AEs. SYNB1934: 1 participant discontinued at Day 1 due to mis- -dosing and GI AEs; 3 participants discontinued in …

Category:  Health Go Health

Redesigning Medicine Using Synthetic Biology

WEBexperimental approaches are needed to understand the underlying mechanisms for how interactions between the gut microbiota and the host affect human health and disease.

Category:  Health Go Health

Developing a new class of engineered live bacterial …

WEBLBPs are distinguished from probiotic supplements on the basis of their labeling claims, as. 1Synlogic, Inc., 301 Binney Street, Cambridge, MA 02142, USA. email: …

Category:  Supplements Go Health

A Novel Human IL-22- Secreting Synthetic Biotic Medicine for …

WEBSummary. Engineered EcN secretes high levels of bioactive hIL-22 in vitro. EcN-hIL-22 is viable in different compartments of the mouse inflamed gut. EcN-hIL-22 …

Category:  Health Go Health

Synlogic Announces International Nonproprietary Name Selection …

WEBThe World Health Organization has approved “labafenogene marselecobac”. Name attributes recognize Synlogic’s proprietary technology and commitment to …

Category:  Health Go Health

Synlogic and Mirna Therapeutics Agree to Merger

WEB– Transaction Expected to Advance Synlogic’s Innovative Platform for the Discovery and Development of Novel Synthetic Biotic™ Medicines – – Synlogic Closes …

Category:  Medicine Go Health

Synlogic Meets First Discovery Milestone in Partnership with …

WEBDiscoveries support next phase of collaboration with AbbVie – Cambridge, Mass (Business Wire) – Synlogic™ has completed the first phase of its ongoing collaboration with …

Category:  Health Go Health

Synlogic to Present at Jefferies 2017 Global Healthcare Conference

WEBThe Investor Relations website contains information about Synlogic's business for stockholders, potential investors, and financial analysts.

Category:  Health Go Health

Synlogic at the Cowen 40th Annual Health Care Conference

WEBMar 2, 2020 at 2:10 PM EST Investor Resources. Contact IR; Investor FAQs; RSS Feeds; Investor Email Alerts

Category:  Health Go Health

Jerry Vockley, M.D., Ph.D.

WEBSafety Profile of SYNB1618. Generally well-tolerated in HV and PKU. 56 healthy volunteers and 14 PKU patients. Adults Age range: 18-62 yrs old (20-50 yrs in PKU) Received at …

Category:  Health Go Health

Synlogic Appoints Lisa Kelly-Croswell to its Board of Directors

WEBFebruary 10, 2021. PDF Version. CAMBRIDGE, Mass., Feb. 10, 2021 /PRNewswire/ -- Synlogic, Inc. (Nasdaq: SYBX), a clinical stage company bringing the transformative …

Category:  Health Go Health

2023 Jefferies Healthcare Conference

WEB2:00-2:25 PM EDT (Track 2) Aoife Brennan, M.B. Ch.B., President and Chief Executive Officer, will present at the 2023 Jefferies Healthcare Conference being held in New …

Category:  Health Go Health

Engineered bacteria producing aryl‐hydrocarbon receptor …

WEB2 | KOUNO ET AL. INTRODUCTION Alcohol-associated liver disease is a spectrum of liver diseases rang-ing from simple steatosis to fibrosis, cirrhosis, and alcohol-associated

Category:  Health Go Health